Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry

@inproceedings{Cheraghali2012BiosimilarsAU,
  title={Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry},
  author={Abdol Majid Cheraghali},
  booktitle={DARU Journal of Pharmaceutical Sciences},
  year={2012}
}
In 1980s, medicines produced through recombinant DNA technology created a novel opportunity for management of several debilitating and life threatening diseases. However, these medicines are very expensive and therefore not affordable for many patients especially those living in low resourced countries. Biopharmaceuticals mostly have a high unit cost and often prescribed for chronic medical conditions with possibility of longterm use. Therefore, they will impose a burden on either national… CONTINUE READING
Highly Cited
This paper has 276 citations. REVIEW CITATIONS

Topics

Statistics

0200400201320142015201620172018
Citations per Year

276 Citations

Semantic Scholar estimates that this publication has 276 citations based on the available data.

See our FAQ for additional information.